Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized double-blind study of mesenchymal stem cells in matched unrelated allogeneic hematopoietic stem cell transplantation
2008-005594-35Phase 3Terminated
- Sponsor
- Centre Hospitalier Universitaire de Liège
- Start
- Aug 2009
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mesenchymal stem cells in hematopoietic malignancies, Congenital Metabolic Diseases and Acute Graft-Versus-Host Disease (aGvHD) (2 arms), sponsored by Centre Hospitalier Universitaire de Liège. Primary endpoints: Time to neutrophil engraftment and Incidence of acute graft-versus-host disease grade II-IV. Started Aug 2009; status: terminated.
02
Drugs
mesenchymal stem cells
03
Conditions
hematopoietic malignanciesCongenital Metabolic DiseasesAcute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on 2008-005594-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005594-35.